Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin

Atherosclerosis

Volumn 209, Issue 1, 2010, Pages 89-95

  Digby, Janet E ^a   McNeill, Eileen ^a   Dyar, Oliver J ^a   Lam, Vincent ^a   Greaves, David R ^a   Choudhury, Robin P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adipocyte; Adipose tissue; Chemokine; Inflammation; Niacin; Nicotinic acid

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHEMOKINE; FRACTALKINE; G PROTEIN COUPLED RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINIC ACID; PERTUSSIS TOXIN; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CELL STRAIN 3T3; CELL VIABILITY; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION;

3T3 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATHEROSCLEROSIS; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CX3CL1; CULTURE MEDIA, CONDITIONED; MICE; NIACIN; RECEPTORS, G-PROTEIN-COUPLED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77049084050     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.08.045     Document Type: Article

References (29)

1. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 (2006) 898-918
2. Suganami T., Nishida J., and Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25 (2005) 2062-2068
3. Berg A.H., Lin Y., Lisanti M.P., and Scherer P.E. Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. Am J Physiol Endocrinol Metab 287 (2004) E1178-1188
4. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
5. Liu K.H., Chan Y.L., Chan J.C.N., and Chan W.B. Association of carotid intima-media thickness with mesenteric, preperitoneal and subcutaneous fat thickness. Atherosclerosis 179 (2005) 299
6. Danias P.G., Tritos N.A., Stuber M., Botnar R.M., Kissinger K.V., and Manning W.J. Comparison of aortic elasticity determined by cardiovascular magnetic resonance imaging in obese versus lean adults. Am J Cardiol 91 (2003) 195-199
7. Diamant M., Lamb H.J., van de Ree M.A., et al. The Association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab 90 (2005) 1495-1501
8. Montani J.P., Carroll J.F., Dwyer T.M., Antic V., Yang Z., and Dulloo A.G. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 28 suppl. 4 (2004) S58-65
9. Mazurek T., Zhang L., Zalewski A., et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108 (2003) 2460-2466
10. Henrichot E., Juge-Aubry C.E., Pernin A., et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?. Arterioscler Thromb Vasc Biol 25 (2005) 2594-2599
11. Peterson M.J., Hillman C.C., and Ashmore J. Nicotinic acid: studies on the mechamism of its antilipolytic action. Mol Pharmacol 4 (1968) 1-9
12. Tunaru S., Kero J., Schaub A., et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9 (2003) 352-355
13. Wise A., Foord S.M., Fraser N.J., et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 278 (2003) 9869-9874
14. Knopp R.H. Drug treatment of lipid disorders. N Engl J Med 341 (1999) 498-511
15. Brown B.G., and Zhao X.Q. Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk. Am J Cardiol 101 (2008) 58B-62
16. Westphal S., Borucki K., Taneva E., Makarova R., and Luley C. Extended-release niacin raises adiponectin and leptin. Atherosclerosis 193 (2007) 361-365
17. Kapur S., Marcotte B., and Marette A. Mechanism of adipose tissue iNOS induction in endotoxemia. Am J Physiol 276 (1999) E635-641
18. Canner P.L., Berge K.G., Wenger N.K., et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 8 (1986) 1245-1255
19. Canner P.L., Furberg C.D., and McGovern M.E. Benefits of niacin in patients with versus without the metabolic syndrome and healed myocardial infarction (from the Coronary Drug Project). Am J Cardiol 97 (2006) 477-479
20. Plaisance E.P., Lukasova M., Offermanns S., Zhang Y., Cao G., and Judd R.L. Niacin stimulates adiponectin secretion through the GPR109A receptor. Am J Physiol Endocrinol Metab 296 (2009) E549-E558
21. Linke A., Sonnabend M., Fasshauer M., Hollriegel R., Schuler G., Niebauer J., Stumvoll M., and Bluher M. Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance. Atherosclerosis 205 (2009) 207-213
22. Lee JM, Robson MD, Yu L-M, Shirodaria CC, Cunnington C, Kylintireas I, Bannister T, Wiesmann F, Handa A, Channon KM, Neubauer SE, Choudhury RP. High dose modified-release nicotinic acid reduces carotid atherosclerosis: a randomized, placebo-controlled magnetic resonance study. JACC 2009; accepted for publication.
23. Gustafson B., Hammarstedt A., Andersson C.X., and Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27 (2007) 2276-2283
24. Tacke F., Alvarez D., Kaplan T.J., et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117 (2007) 185-194
25. Rocha V.Z., Folco E.J., Sukhova G., et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 103 (2008) 467-476
26. Koh S.J., Kim J.Y., Hyun Y.J., Park S.H., Chae J.S., Park S., Kim J.S., Youn J.C., Jang Y., and Lee J.H. Association of serum RANTES concentrations with established cardiovascular risk markers in middle-aged subjects. Int J Cardiol 132 (2009) 102-108
27. Hansson G.K., and Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6 (2006) 508-519
28. Kern P.A., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280 (2001) E745-751
29. Unoki H., Bujo H., Jiang M., Kawamura T., Murakami K., and Saito Y. Macrophages regulate tumor necrosis factor-alpha expression in adipocytes through the secretion of matrix metalloproteinase-3. Int J Obes (Lond) 32 (2008) 902-911